Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 162,752 | 136,804 | 115,715 | 100,178 | 148,520 |
| Gross Profit | 162,752 | 136,804 | 115,715 | 100,178 | 148,520 |
| Operating Expenses | 6,920 | 4,582 | 7,861 | 7,925 | 6,783 |
| Operating Income | 155,832 | 132,222 | 107,854 | 92,253 | 141,737 |
| Interest Expense | 9,858 | 10,525 | 6,702 | 6,118 | 6,051 |
| Other Income | 82 | -6,093 | -3,709 | 53 | 60 |
| Pre-tax Income | 146,056 | 115,604 | 97,443 | 86,188 | 135,746 |
| Income Tax | 54,001 | 42,721 | 36,351 | 29,963 | 42,004 |
| Net Income Continuous | 92,055 | 72,883 | 61,092 | 56,225 | 93,742 |
| Net Income | $92,055 | $72,883 | $61,092 | $56,225 | $93,742 |
| EPS Basic Total Ops | 0.57 | 0.48 | 0.44 | 0.40 | 0.67 |
| EPS Basic Continuous Ops | 0.57 | 0.48 | 0.44 | 0.40 | 0.67 |
| EPS Diluted Total Ops | 0.52 | 0.44 | 0.32 | 0.36 | 0.62 |
| EPS Diluted Continuous Ops | 0.52 | 0.44 | 0.32 | 0.36 | 0.62 |
| EBITDA(a) | $160,534 | $136,994 | $111,209 | $95,476 | $144,774 |